Welcome to Staidson Biopharma

We are a biopharmaceutical company dedicated to developing novel antibody and protein drugs to fight cancer and diseases for unmet clinical needs.


At Staidson, we are harnessing the power of functional genomics, structural biology, cutting edge technologies and newly immunology concepts to discover and deliver transformative medicine to patients, and to improve the quality of their lives.


Built on the twin pillars of cutting edge antibody discovery and our unique PepBodyTM platform, Staidson Biopharma’s Biology division is pioneering development of next generation therapies for the most intractable issues plaguing the fields of autoimmune disease and immuno-oncology

Read More